Navigation Links
The Boston Eye Group Implants First Intraocular Pressure Transducer for Glaucoma Monitoring
Date:1/25/2013

Brookline, MA (PRWEB) January 25, 2013

Glaucoma is characterized by slow, painless loss of vision due to optic nerve damage mostly related to an elevated eye pressure. Until now, doctors have relied on in-office methods to measure the eye pressure.This requires a visit to the doctor’s office every few weeks to few months. A new surgically implanted device may for the first time allow home monitoring of eye pressure.Once inside the eye, it relays measurements to a remote-held reader wirelessly.

Following years of animal research, Samir Melki MD PhD of Harvard Medical School and the Boston Eye Group implanted the device for the first time in a patient with Glaucoma during cataract surgery. “This may be a game-changer when it comes to glaucoma management” said Dr. Melki. “ It should allow us to understand the disease through a tremendous ability to collect pressure data”

The wireless intraocular pressure transducerwas developed by Implandata GmbH (Hannover, Germany). It integrates pressure sensors, temperature sensor, identification encoder, analog-to-digital encoder, and telemetry unit into a single microelectromechanical system-application specific integrated circuit (MEMS-ASIC). This digital ultra-miniature system employs complementary metal oxide semiconductor (CMOS) technology for its electronic components. The electronic components are either biocompatible or inert. The ASIC is attached to a circular microcoil antenna made of gold and both of these components are hermetically encapsulated in platinum-cured silicone. This biocompatible silicone material makes up the entire surface of the implant. The implant itself is designed to remain in-vivo indefinitely. The outside diameter of the transponder disc is only 11.3 mm, inside diameter is 7 mm, its thickness is 0.9 mm and the weight is 0.1 g.

“The device seems to be very well tolerated in the eye” said Melki, who implanted the device 18months ago at the Beirut Eye Specialist Hospital. “Although more studies need to be conducted, we have seen no side effects until now”.

There are several benefits to the novelmethod.It allows IOP measurements wirelessly through radiofrequency whichoffers the prospect of lifelong frequent eye pressure monitoring. It may reduce the number of doctors’ visits and provide measurements at times that were inaccessible previously such as during sleep. This may allow glaucoma specialists to understand why certain patients still lose vision despite seemingly low pressures. The device is not FDA-approved at this time.

For more information, contact Rick Young at Rick(at)bostoneyegroup(dot)com or Max Ostermeier at mostermeier(at)implandata(dot)com. You can also visit http://www.bostoneyegroup.com or call 617-566-0062.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10354744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Linguists to gather in Boston for National Conference
2. Northofbostonusa.com Will Release its N5 Fashion Shoes Next Monday
3. Boston College researcher looks to stop a deadly parasite in its tracks
4. Boston Medical Center awarded elite distinction as a 2012 Leapfrog Top Hospital
5. Cincinnati and Boston Childrens Hospitals receive an NIH Autism Center of Excellence Grant
6. Boston University researchers expand synthetic biologys toolkit
7. Snoring Isn’t Sexy Member, Dr. Mark Levy attends the American Academy of Dental Sleep Medicine Meeting in Boston, MA
8. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
9. Boston researcher, surgical oncologist receives national award
10. Leaders in childrens health to gather in Boston
11. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance and ... to clients in southern Montana, is announcing a focused charity effort to gather ... outreach programs offered by Zoo Montana provide students with current knowledge on the ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... MA (PRWEB) , ... June 27, 2017 , ... The ... Senate bill to repeal and replace the 2010 Patient Protection and Affordable Care Act ... compared with what would be expected under current law. , More than 20 million ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on medGadget ... $6.81 billion by the year 2024 according to a new report. The article also ... made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology: